U.S. Metals and Mining Stock News

Recent analyst reports on Atour Lifestyle Holdings (NasdaqGS:ATAT) have focused on upward revisions to earnings estimates and a Zacks Rank #1. This has drawn fresh attention to the stock within the leisure and recreation services sector. See our latest analysis for Atour Lifestyle Holdings. Atour Lifestyle Holdings has seen short term momentum pick up, with a 12.30% 7 day share price return and 9.31% 30 day share price return, although the share price is still down 11.39% year to date. The 3...

In the past week, uniQure N.V. reported Q2 2026 results showing revenue of US$5.84 million alongside a much larger quarterly net loss of US$81.06 million, while also filing a US$12.83 million shelf registration for 350,000 ordinary shares tied to its employee share plan. At the same time, the company advanced its regulatory plans for AMT-130 in Huntington’s disease and highlighted promising early data in epilepsy and Fabry programs, framing a contrast between widening losses and progress in...

Textron (TXT) is back in focus after its latest update combined several key signals. The company reported second quarter results, reaffirmed full year 2026 earnings guidance, and confirmed completion of a planned share repurchase tranche. See our latest analysis for Textron. Textron's recent earnings beat, reiterated 2026 guidance and completion of its buyback tranche came as the share price fell 4.8% on the day and 10.7% over 90 days, while the 1 year total shareholder return of 9.8% points...

Novanta (NasdaqGS:NOVT) has completed its acquisition of Riverpoint Medical. The deal significantly increases Novanta's exposure to the medical consumables market. Management expects the transaction to approximately double recurring medical consumables revenue. Novanta focuses on precision photonics, vision and motion technologies used in medical and advanced industrial applications. With Riverpoint Medical now under its umbrella, the company gains a larger footprint in medical consumables,...

Owens Corning recently announced that Jonathan Collins will become Executive Vice President and Chief Financial Officer on August 10, 2026, succeeding Todd Fister, who moves into the newly defined role of President and Chief Operating Officer to oversee enterprise initiatives and operational execution. The appointment brings in a finance leader with experience integrating generative AI and managing complex transformations, while freeing Fister to concentrate on aligning operations and...

In late July 2026, SS&C Technologies Holdings, Inc. filed a US$779 million shelf registration for 10,000,000 common shares tied to an ESOP-related offering, shortly after reporting second-quarter 2026 revenue of US$1,695.7 million and net income of US$234.8 million, both higher than the prior year. The earnings release also showed higher basic and diluted earnings per share from continuing operations for both the quarter and first half of 2026, pointing to improved profitability alongside...

Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA seeking to extend KHINDIVI’s hydrocortisone oral solution label to younger pediatric patients with adrenocortical insufficiency, beyond its current approval for those aged five and older. This move, backed by bioequivalence data versus ALKINDI SPRINKLE, could broaden treatment options in a rare disease population where Eton estimates about 10,000 U.S. pediatric patients. With KHINDIVI already the only FDA-approved...

Pentair stock has fallen sharply this year, yet the company still screens as undervalued on several key checks, including an intrinsic value estimate that sits well above the current share price. With sentiment hit by legal investigations and weaker trading in parts of the business, investors are weighing whether the current discount fairly reflects the risks now in play. Year to date, Pentair shares are down 36.9%, which means current holders have taken a sizeable hit and new investors are...

Flex stock reacts to record quarter and raised 2027 outlook Flex (FLEX) is back in focus after reporting record first quarter fiscal 2027 earnings, lifting full year revenue guidance and confirming plans to separate its Cloud and Power Infrastructure business. See our latest analysis for Flex. The sharp share price pullback after earnings, including a 1-day share price return that declined 9.06% and a 30-day share price return that fell 36.43%, comes after very strong long term momentum, with...

StoneCo (STNE) is back in focus after the stock fell 2.15%, lagging major indexes, as investors look ahead to the company’s August 13, 2026 earnings release. See our latest analysis for StoneCo. The recent 1-day share price return decline of 1.79% and 7-day decline of 3.52% extend a weaker short term trend for StoneCo. At the same time, the 1-year total shareholder return of 2.45% and 5-year total shareholder return decline of 76.58% point to mixed longer term outcomes around the current...

Viridian Therapeutics recently reported positive topline results from its Elegrobart REVEAL-1 phase III trial in Graves' ophthalmopathy and outlined plans to submit a Biologics License Application in early 2027. This progress, combined with the recent approval of Viridian’s LUMVOA and a pipeline that includes other emerging therapies for Graves’ ophthalmopathy, highlights the company’s growing role in this specialized autoimmune eye disease market. We’ll now examine how the positive...

Fed Chair Kevin Warsh’s move to dial back forward guidance has left markets more data driven and, at times, more jumpy. When rate clues are harder to read, many investors start to focus on stocks that have shown relatively low price swings and steadier profiles. That is where a low volatility screener can help filter the chaos. This article looks at three stocks from that list that appear positively exposed to the current policy uncertainty and recent volatility in Treasury yields, and...

Adobe, ticker NasdaqGS:ADBE, has joined a new coalition to launch the Open Source AI Cybersecurity Alliance. The alliance focuses on open source collaboration to improve cybersecurity for artificial intelligence systems. This company initiative has not been widely covered in recent Adobe news as of July 2026. Adobe is best known for its creative and digital experience software, but its role in AI has been growing across products and services. Joining the Open Source AI Cybersecurity...

Northrop Grumman stock has delivered a 62.4% gain over the past five years, yet current valuation checks and intrinsic value estimates both point to the shares trading below what the underlying cash flows imply. With market sentiment still digesting mixed shorter term returns, the question is whether the current price fully reflects the company’s long term contract and earnings profile. Over five years, Northrop Grumman has returned 62.4%, which suggests long term holders have been rewarded...

Investors watching the latest Goldman Sachs tribunal decision on sex discrimination and unfair dismissal can see how quickly employment disputes turn into real financial and reputational costs. Human resources and employment law services sit close to this pressure point, from compliance advice to managing workplace disputes. When a £1.45mn award and critical findings on dismissal processes hit headlines, that can influence how companies think about risk management and where they spend on...

AppLovin (APP) is back in focus after fresh analyst commentary highlighted expectations for quarterly results above the company’s guidance, with particular attention on the gaming segment and sequential revenue trends. See our latest analysis for AppLovin. Recent excitement around AppLovin’s expected results sits against a weaker near term trend, with the share price down 19.91% over 30 days and 35.40% year to date. However, a 3 year total shareholder return above 10x still points to strong...

Why Stanley Black & Decker Stock Is Back in Focus After Q2 Earnings Stanley Black & Decker (SWK) moved back onto investors’ radar after second quarter results showed net income of $351.3 million and higher earnings per share, alongside a raised 2026 GAAP EPS outlook. See our latest analysis for Stanley Black & Decker. After these Q2 results and the raised 2026 GAAP EPS outlook, Stanley Black & Decker’s share price at US$93.05 sits on a year to date share price return of 21.68%. The 1 year...

Gartner stock has had a tough run over the past year, yet current valuation checks suggest the share price may now sit below what its Discounted Cash Flow (DCF) and earnings multiple signals imply for intrinsic value. Over the past 12 months the share price has fallen 51.8%, which puts recent gains into context and raises the question of whether sentiment has moved further than the fundamentals. Recent headlines around Gartner's AI forecasts and its role in shaping spending on AI...

Nexstar Media Group (NXST) is drawing attention after announcing that its Kansas stations will air a live, multi market telecast of the Democratic governor candidates' debate on July 31 across TV and digital platforms. See our latest analysis for Nexstar Media Group. The debate announcement comes as Nexstar Media Group’s recent momentum has picked up, with a 7 day share price return of 8.71% and a 30 day share price return of 10.27%, even though the year to date share price return is down...

Viatris Inc. recently received U.S. Food and Drug Administration approval for Gwyn Lo, a once-weekly low-estrogen combined hormonal contraceptive patch for women with a body mass index below 30 kg/m², supported by Phase 3 data showing contraceptive efficacy, a well-characterized safety profile and strong patch adhesion. By adding a low-dose, non-invasive, weekly contraceptive option that targets women seeking convenience and reversibility, Viatris is broadening its branded and complex...

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...

Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue compared with last year and a cautious Zacks Rank of #4. See our latest analysis for Tarsus Pharmaceuticals. At a share price of US$58.52, Tarsus Pharmaceuticals has seen its share price decline 27.6% year to date, even though the 1 year total shareholder return is 46.3%. This suggests long term holders are still sitting on strong gains despite...

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...